Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Class of 2025
Hammarskjold High School
Superior Collegiate and Vocational Institute
Westgate Collegiate & Vocational Institute
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
IQVIA Holdings, Inc. Common Stock
(NY:
IQV
)
162.80
-2.73 (-1.65%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IQVIA Holdings, Inc. Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
IQVIA Reports Fourth-Quarter and Full-Year 2022 Results; Issues Full-Year 2023 Guidance
February 10, 2023
From
IQVIA Holdings Inc.
Via
Business Wire
PayPal, Global Payments And 3 Stocks To Watch Heading Into Friday
February 10, 2023
With US futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Optimism Declines Slightly As Dow Drops 250 Points
February 10, 2023
The CNN Money Fear and Greed index showed some decline in the overall sentiment among US investors. US stocks closed lower on Thursday as investors assessed recent batch of corporate earnings.
Via
Benzinga
IQVIA Named to FORTUNE’s 2023 List of “World’s Most Admired Companies,” Ranked #1 in Its Category for the Second Consecutive Year
February 09, 2023
From
IQVIA
Via
Business Wire
Earnings Outlook For IQVIA Holdings
February 09, 2023
Via
Benzinga
Will Investors Notice Exciting Sign On IQVIA Hldgs's Chart?
January 23, 2023
Via
Benzinga
Analyst Ratings for IQVIA Hldgs
January 13, 2023
Via
Benzinga
Expert Ratings for IQVIA Hldgs
December 06, 2022
Via
Benzinga
Where IQVIA Hldgs Stands With Analysts
November 17, 2022
Via
Benzinga
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
February 07, 2023
These companies are changing their industries.
Via
The Motley Fool
IQVIA in Collaboration with Alibaba Cloud to Deliver Commercial & Clinical Solutions in China
January 31, 2023
From
IQVIA
Via
Business Wire
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
January 25, 2023
From
IQVIA
Via
Business Wire
Analyst Ratings for IQVIA Hldgs
November 17, 2022
Via
Benzinga
8 Analysts Have This to Say About IQVIA Hldgs
October 27, 2022
IQVIA Hldgs (NYSE:IQV) has observed the following analyst ratings within the last quarter:
Via
Benzinga
7 Analysts Have This to Say About IQVIA Hldgs
October 06, 2022
Analysts have provided the following ratings for IQVIA Hldgs (NYSE:IQV) within the last quarter:
Via
Benzinga
Global Market for Medicines to Rise to $1.9 Trillion by 2027, says Report from IQVIA Institute
January 18, 2023
From
IQVIA
Via
Business Wire
World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday
January 17, 2023
Goldman Sachs boosted the price target for The Wendy's Company (NASDAQ: WEN) from $22 to $25. Goldman Sachs analyst Jared Garber maintained a Neutral rating on the stock. Wendy's shares fell 1.4% to...
Via
Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
January 11, 2023
These healthcare companies' revenue and earnings have grown, and they expect more growth.
Via
The Motley Fool
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
December 01, 2022
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
December 06, 2022
Via
Benzinga
Target To Rally 29%? Plus This Analyst Predicts $245 For IQVIA Holdings
November 17, 2022
Piper Sandler boosted the price target on Target Corporation (NYSE: TGT) from $190 to $200. Target shares fell 13.1% to close at $155.47 on Wednesday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Upgrades
Via
Benzinga
IQVIA and Clalit Health Services partner to advance research by launching the first Prime Site in Israel
November 10, 2022
From
IQVIA
Via
Business Wire
General Electric To Rally Around 14%? Here Are 5 Other Price Target Changes For Thursday
October 27, 2022
Morgan Stanley raised General Electric Company (NYSE: GE) price target from $85 to $88. Morgan Stanley analyst Joshua Pokrzywinski maintained the stock with an Overweight rating. GE shares rose 2.2%...
Via
Benzinga
IQVIA: Q3 Earnings Insights
October 26, 2022
IQVIA Hldgs (NYSE:IQV) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings IQVIA Hldgs beat estimated...
Via
Benzinga
IQVIA Reports Third-Quarter 2022 Results
October 26, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies
October 25, 2022
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging.
Via
Investor's Business Daily
Biosimilars Are Revolutionizing Healthcare: Is This Industry Leader a Buy?
October 25, 2022
Biosimilars are bringing down prescription drug costs without sacrificing quality.
Via
The Motley Fool
IQVIA CFO Ron Bruehlman to Speak at Credit Suisse Annual Healthcare Conference on November 8, 2022
October 24, 2022
From
IQVIA Holdings Inc.
Via
Business Wire
Q² Solutions Launches Innovative Self-Collection Safety Lab Panel in Collaboration With Tasso
October 06, 2022
From
IQVIA
Via
Business Wire
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.